Four-Year-Old Hospitalized in Serious Condition With Invasive Meningococcal Infection
Translated & summarized from Mako by baba
A four-year-old boy is in serious condition at Wolfson Medical Center in Holon due to an invasive meningococcal infection. The hospital described the bacteria as extremely dangerous and fast-acting, emphasizing the need for rapid diagnosis and treatment.
The story in 5 lines · by baba
- Four-year-old hospitalized with severe meningococcal infection.
- Hospital calls it a dangerous and rapidly progressing illness.
- Infection can cause system collapse within hours.
- Symptoms initially mimic common viral illnesses.
- Vaccine available for the most common strain.
A four-year-old boy has been hospitalized in serious condition at Wolfson Medical Center in Holon after being diagnosed with an invasive meningococcal infection. The child was rushed to the emergency room exhibiting rapidly developing symptoms, which were later identified as stemming from the aggressive bacteria.
"This is one of the most violent, dangerous, and rapidly progressing infections we know in pediatric medicine," a statement from the hospital read. "The meningococcal bacteria can attack a completely healthy person and lead to system collapse, septic shock, and a real life-threatening situation within just a few hours."
The hospital explained that the bacteria commonly resides in the throat of 10-20% of the population and can sometimes transition from a carrier state to active illness. In severe cases, it can enter the bloodstream or nervous system, causing meningitis or sepsis (blood poisoning).
Dr. Diana Tcher, head of pediatrics at Wolfson Medical Center, highlighted the diagnostic challenge, noting that initial symptoms like fever, weakness, and muscle or headaches are non-specific and resemble common viral illnesses. However, the rapid progression of the disease, which can lead to severe illness within 24 to 48 hours, makes prompt diagnosis and treatment critical.
The infection most frequently affects infants and toddlers aged 0 to 2 years, as well as those living in crowded conditions or with compromised immune systems. The hospital noted that a vaccine against serogroup B, the most common strain in Israel, is available (Bexsero). While not part of the routine vaccination schedule, it is highly recommended for all children up to age 5, particularly those under two.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 7Right 4Haredi 3Other 3